BioDlink International Company Limited (1875.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
No. 120 Changyang Street
Suzhou, 215024
China
Phone
86 512 6296 5186
Sector
Healthcare
Industry
Biotechnology
Employees
611
First IPO Date
November 08, 2019
| Name | Title | Pay | Year Born |
| Jincai Li | Executive Chairperson of the Board | 0 | 1973 |
| Li Yin | Chief Technology Officer | 0 | 1966 |
| Wing Yat Lui | Joint Company Secretary | 0 | 1990 |
| Yifan Chen | Joint Company Secretary | 0 | 1980 |
| Ben Xiao | Group Vice President of Finance & Investor Relations | 0 | 1982 |
| Jian Bo Zhang | Chief Operating Officer | 0 | 1978 |
| Shan Fu | Executive Chairperson of the Board | 0 | 1969 |
BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated in Suzhou, China.